All content is freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission of the publisher or the author. Articles published in the journal are distributed under a http://creativecommons.org/licenses/by/4.0/.
ORGANISATIONAL HAZARDS IN BIOTECHNOLOGY — TOWARDS A NEW RISK ASSESSMENT PROGRAM
Ditta Bartels.
Original Articles
Great progress in the field of recombinant DNA technology has masked concern about the safety of the procedures involved. It seems that those carrying out oncogene research using these techniques may be exposed to considerable danger of contracting cancer. A thorough program to assess the risks involved is required to replace the complacency of ignorance which now exist, and it is required before rather than after damage is done.
